Vivek Subbiah: A delight to interview Dr. Kemi Doll

Vivek Subbiah shared on LinkedIn:

“It was a delight to interview Dr. Kemi Doll a gynecologic oncologist, health services researcher, the CEO of KD Coach & co-founder of ECANA Women and author of a recent paper published in JAMA Oncology !.

Don’t miss this podcast. Hosted on American Medical Association Ed Hub

Interview with Kemi M. Doll, MD, author of Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. Hosted by Vivek Subbiah.”

Read further.
Source: Vivek Subbiah/LinkedIn

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA).

He is the former Executive Director of Oncology Research at the MD Anderson Cancer Network and a former Associate Professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center.

Dr. Vivek Subbiah has served as the principal investigator in over 100 phase I/II trials and co-investigator in over 200 clinical trials and is known for his leadership in several first-in-human and practice-changing studies that directly led to approvals from the FDA, European Medicines Agency, and other agencies across the world.